Report Detail
Global and United States Opioid Receptor Agonist Market Report & Forecast 2022-2028
- RnM4401645 |
- 17 March, 2022 |
- Global |
- 111 Pages |
- QYResearch |
- Pharma & Healthcare
Summary:
Opioids are a type of painkiller that works by acting on the neurological system. They're mostly utilized for anaesthetic and pain relief. An agonist is a pharmacological molecule that activates specific brain receptors. When only a small number of receptors are engaged, this agonist elicits a strong physiological/pharmacological response, indicating that the medication has high intrinsic activity. Fentanyl, morphine, dihydromorphinone, meperidine, oxycodone, and oxymorphone are all strong agonist opioids. Opioid receptors are G-protein-coupled inhibitors that are primarily found in peripheral tissues and interfere with opioid receptors' pain-signaling function. Agonists are pain relievers that function by binding opioid receptors and reducing pain experience.
Market Analysis and Insights: Global and United States Opioid Receptor Agonist Market
This report focuses on global and United States Opioid Receptor Agonist market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Opioid Receptor Agonist market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Fentanyl accounting for % of the Opioid Receptor Agonist global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Hospital Pharmacy was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
In United States the Opioid Receptor Agonist market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
Global Opioid Receptor Agonist Scope and Market Size
Opioid Receptor Agonist market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Opioid Receptor Agonist market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Opioid Receptor Agonist market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type, the Opioid Receptor Agonist market is segmented into
Fentanyl
Codeine
Morphine
Others
Segment by Application, the Opioid Receptor Agonist market is segmented into
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
Regional and Country-level Analysis
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Competitive Landscape and Opioid Receptor Agonist Market Share Analysis
Opioid Receptor Agonist market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Opioid Receptor Agonist business, the date to enter into the Opioid Receptor Agonist market, Opioid Receptor Agonist product introduction, recent developments, etc.
The major vendors covered:
Teva Pharmaceutical Industries
Johnson & Johnson
Pfizer
Fresenius Kabi
Mylan N.V.
Allergan
US WorldMeds
Piramal Critical Care
DAIICHI SANKYO COMPANY
Purdue Pharma
Hikma Pharmaceuticals
Endo Pharmaceuticals
Sun Pharmaceutical Industries
Tris Pharma
Indivior
Table of Contents
1 Study Coverage
- 1.1 Opioid Receptor Agonist Product Introduction
- 1.2 Global Opioid Receptor Agonist Outlook 2017 VS 2022 VS 2028
- 1.2.1 Global Opioid Receptor Agonist Sales in US$ Million for the Year 2017-2028
- 1.2.2 Global Opioid Receptor Agonist Sales in Volume for the Year 2017-2028
- 1.3 United States Opioid Receptor Agonist Outlook 2017 VS 2022 VS 2028
- 1.3.1 United States Opioid Receptor Agonist Sales in US$ Million for the Year 2017-2028
- 1.3.2 United States Opioid Receptor Agonist Sales in Volume for the Year 2017-2028
- 1.4 Opioid Receptor Agonist Market Size, United States VS Global, 2017 VS 2022 VS 2028
- 1.4.1 The Market Share of United States Opioid Receptor Agonist in Global, 2017 VS 2022 VS 2028
- 1.4.2 The Growth Rate of Opioid Receptor Agonist Market Size, United States VS Global, 2017 VS 2022 VS 2028
- 1.5 Opioid Receptor Agonist Market Dynamics
- 1.5.1 Opioid Receptor Agonist Industry Trends
- 1.5.2 Opioid Receptor Agonist Market Drivers
- 1.5.3 Opioid Receptor Agonist Market Challenges
- 1.5.4 Opioid Receptor Agonist Market Restraints
- 1.6 Study Objectives
- 1.7 Years Considered
2 Market by Type
- 2.1 Opioid Receptor Agonist Market Segment by Type
- 2.1.1 Fentanyl
- 2.1.2 Codeine
- 2.1.3 Morphine
- 2.1.4 Others
- 2.2 Global Opioid Receptor Agonist Market Size by Type
- 2.2.1 Global Opioid Receptor Agonist Sales in Value, by Type (2017, 2022 & 2028)
- 2.2.2 Global Opioid Receptor Agonist Sales in Volume, by Type (2017, 2022 & 2028)
- 2.2.3 Global Opioid Receptor Agonist Average Selling Price (ASP) by Type (2017, 2022 & 2028)
- 2.3 United States Opioid Receptor Agonist Market Size by Type
- 2.3.1 United States Opioid Receptor Agonist Sales in Value, by Type (2017, 2022 & 2028)
- 2.3.2 United States Opioid Receptor Agonist Sales in Volume, by Type (2017, 2022 & 2028)
- 2.3.3 United States Opioid Receptor Agonist Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
- 3.1 Opioid Receptor Agonist Market Segment by Application
- 3.1.1 Hospital Pharmacy
- 3.1.2 Online Pharmacy
- 3.1.3 Retail Pharmacy
- 3.2 Global Opioid Receptor Agonist Market Size by Application
- 3.2.1 Global Opioid Receptor Agonist Sales in Value, by Application (2017, 2022 & 2028)
- 3.2.2 Global Opioid Receptor Agonist Sales in Volume, by Application (2017, 2022 & 2028)
- 3.3.3 Global Opioid Receptor Agonist Average Selling Price (ASP) by Application (2017, 2022 & 2028)
- 3.3 United States Opioid Receptor Agonist Market Size by Application
- 3.3.1 United States Opioid Receptor Agonist Sales in Value, by Application (2017, 2022 & 2028)
- 3.3.2 United States Opioid Receptor Agonist Sales in Volume, by Application (2017, 2022 & 2028)
- 3.3.3 United States Opioid Receptor Agonist Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Opioid Receptor Agonist Competitor Landscape by Company
- 4.1 Global Opioid Receptor Agonist Market Size by Company
- 4.1.1 Top Global Opioid Receptor Agonist Manufacturers Ranked by Revenue (2021)
- 4.1.2 Global Opioid Receptor Agonist Revenue by Manufacturer (2017-2022)
- 4.1.3 Global Opioid Receptor Agonist Sales by Manufacturer (2017-2022)
- 4.1.4 Global Opioid Receptor Agonist Price by Manufacturer (2017-2022)
- 4.2 Global Opioid Receptor Agonist Concentration Ratio (CR)
- 4.2.1 Opioid Receptor Agonist Market Concentration Ratio (CR) (2017-2022)
- 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Opioid Receptor Agonist in 2021
- 4.2.3 Global Opioid Receptor Agonist Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 4.3 Global Opioid Receptor Agonist Manufacturing Base Distribution, Product Type
- 4.3.1 Global Opioid Receptor Agonist Manufacturers, Headquarters and Distribution of Producing Region
- 4.3.2 Manufacturers Opioid Receptor Agonist Product Type
- 4.3.3 Date of International Manufacturers Enter into Opioid Receptor Agonist Market
- 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
- 4.5 United States Opioid Receptor Agonist Market Size by Company
- 4.5.1 Top Opioid Receptor Agonist Players in United States, Ranked by Revenue (2021)
- 4.5.2 United States Opioid Receptor Agonist Revenue by Players (2020, 2021 & 2022)
- 4.5.3 United States Opioid Receptor Agonist Sales by Players (2020, 2021 & 2022)
5 Global Opioid Receptor Agonist Market Size by Region
- 5.1 Global Opioid Receptor Agonist Market Size by Region: 2017 VS 2022 VS 2028
- 5.2 Global Opioid Receptor Agonist Market Size in Volume by Region (2017-2028)
- 5.2.1 Global Opioid Receptor Agonist Sales in Volume by Region: 2017-2022
- 5.2.2 Global Opioid Receptor Agonist Sales in Volume Forecast by Region (2023-2028)
- 5.3 Global Opioid Receptor Agonist Market Size in Value by Region (2017-2028)
- 5.3.1 Global Opioid Receptor Agonist Sales in Value by Region: 2017-2022
- 5.3.2 Global Opioid Receptor Agonist Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
- 6.1 North America
- 6.1.1 North America Opioid Receptor Agonist Market Size YoY Growth 2017-2028
- 6.1.2 North America Opioid Receptor Agonist Market Facts & Figures by Country (2017, 2022 & 2028)
- 6.1.3 United States
- 6.1.4 Canada
- 6.2 Asia-Pacific
- 6.2.1 Asia-Pacific Opioid Receptor Agonist Market Size YoY Growth 2017-2028
- 6.2.2 Asia-Pacific Opioid Receptor Agonist Market Facts & Figures by Region (2017, 2022 & 2028)
- 6.2.3 China
- 6.2.4 Japan
- 6.2.5 South Korea
- 6.2.6 India
- 6.2.7 Australia
- 6.2.8 China Taiwan
- 6.2.9 Indonesia
- 6.2.10 Thailand
- 6.2.11 Malaysia
- 6.3 Europe
- 6.3.1 Europe Opioid Receptor Agonist Market Size YoY Growth 2017-2028
- 6.3.2 Europe Opioid Receptor Agonist Market Facts & Figures by Country (2017, 2022 & 2028)
- 6.3.3 Germany
- 6.3.4 France
- 6.3.5 U.K.
- 6.3.6 Italy
- 6.3.7 Russia
- 6.4 Latin America
- 6.4.1 Latin America Opioid Receptor Agonist Market Size YoY Growth 2017-2028
- 6.4.2 Latin America Opioid Receptor Agonist Market Facts & Figures by Country (2017, 2022 & 2028)
- 6.4.3 Mexico
- 6.4.4 Brazil
- 6.4.5 Argentina
- 6.5 Middle East and Africa
- 6.5.1 Middle East and Africa Opioid Receptor Agonist Market Size YoY Growth 2017-2028
- 6.5.2 Middle East and Africa Opioid Receptor Agonist Market Facts & Figures by Country (2017, 2022 & 2028)
- 6.5.3 Turkey
- 6.5.4 Saudi Arabia
- 6.5.5 UAE
7 Company Profiles
- 7.1 Teva Pharmaceutical Industries
- 7.1.1 Teva Pharmaceutical Industries Corporation Information
- 7.1.2 Teva Pharmaceutical Industries Description and Business Overview
- 7.1.3 Teva Pharmaceutical Industries Opioid Receptor Agonist Sales, Revenue and Gross Margin (2017-2022)
- 7.1.4 Teva Pharmaceutical Industries Opioid Receptor Agonist Products Offered
- 7.1.5 Teva Pharmaceutical Industries Recent Development
- 7.2 Johnson & Johnson
- 7.2.1 Johnson & Johnson Corporation Information
- 7.2.2 Johnson & Johnson Description and Business Overview
- 7.2.3 Johnson & Johnson Opioid Receptor Agonist Sales, Revenue and Gross Margin (2017-2022)
- 7.2.4 Johnson & Johnson Opioid Receptor Agonist Products Offered
- 7.2.5 Johnson & Johnson Recent Development
- 7.3 Pfizer
- 7.3.1 Pfizer Corporation Information
- 7.3.2 Pfizer Description and Business Overview
- 7.3.3 Pfizer Opioid Receptor Agonist Sales, Revenue and Gross Margin (2017-2022)
- 7.3.4 Pfizer Opioid Receptor Agonist Products Offered
- 7.3.5 Pfizer Recent Development
- 7.4 Fresenius Kabi
- 7.4.1 Fresenius Kabi Corporation Information
- 7.4.2 Fresenius Kabi Description and Business Overview
- 7.4.3 Fresenius Kabi Opioid Receptor Agonist Sales, Revenue and Gross Margin (2017-2022)
- 7.4.4 Fresenius Kabi Opioid Receptor Agonist Products Offered
- 7.4.5 Fresenius Kabi Recent Development
- 7.5 Mylan N.V.
- 7.5.1 Mylan N.V. Corporation Information
- 7.5.2 Mylan N.V. Description and Business Overview
- 7.5.3 Mylan N.V. Opioid Receptor Agonist Sales, Revenue and Gross Margin (2017-2022)
- 7.5.4 Mylan N.V. Opioid Receptor Agonist Products Offered
- 7.5.5 Mylan N.V. Recent Development
- 7.6 Allergan
- 7.6.1 Allergan Corporation Information
- 7.6.2 Allergan Description and Business Overview
- 7.6.3 Allergan Opioid Receptor Agonist Sales, Revenue and Gross Margin (2017-2022)
- 7.6.4 Allergan Opioid Receptor Agonist Products Offered
- 7.6.5 Allergan Recent Development
- 7.7 US WorldMeds
- 7.7.1 US WorldMeds Corporation Information
- 7.7.2 US WorldMeds Description and Business Overview
- 7.7.3 US WorldMeds Opioid Receptor Agonist Sales, Revenue and Gross Margin (2017-2022)
- 7.7.4 US WorldMeds Opioid Receptor Agonist Products Offered
- 7.7.5 US WorldMeds Recent Development
- 7.8 Piramal Critical Care
- 7.8.1 Piramal Critical Care Corporation Information
- 7.8.2 Piramal Critical Care Description and Business Overview
- 7.8.3 Piramal Critical Care Opioid Receptor Agonist Sales, Revenue and Gross Margin (2017-2022)
- 7.8.4 Piramal Critical Care Opioid Receptor Agonist Products Offered
- 7.8.5 Piramal Critical Care Recent Development
- 7.9 DAIICHI SANKYO COMPANY
- 7.9.1 DAIICHI SANKYO COMPANY Corporation Information
- 7.9.2 DAIICHI SANKYO COMPANY Description and Business Overview
- 7.9.3 DAIICHI SANKYO COMPANY Opioid Receptor Agonist Sales, Revenue and Gross Margin (2017-2022)
- 7.9.4 DAIICHI SANKYO COMPANY Opioid Receptor Agonist Products Offered
- 7.9.5 DAIICHI SANKYO COMPANY Recent Development
- 7.10 Purdue Pharma
- 7.10.1 Purdue Pharma Corporation Information
- 7.10.2 Purdue Pharma Description and Business Overview
- 7.10.3 Purdue Pharma Opioid Receptor Agonist Sales, Revenue and Gross Margin (2017-2022)
- 7.10.4 Purdue Pharma Opioid Receptor Agonist Products Offered
- 7.10.5 Purdue Pharma Recent Development
- 7.11 Hikma Pharmaceuticals
- 7.11.1 Hikma Pharmaceuticals Corporation Information
- 7.11.2 Hikma Pharmaceuticals Description and Business Overview
- 7.11.3 Hikma Pharmaceuticals Opioid Receptor Agonist Sales, Revenue and Gross Margin (2017-2022)
- 7.11.4 Hikma Pharmaceuticals Opioid Receptor Agonist Products Offered
- 7.11.5 Hikma Pharmaceuticals Recent Development
- 7.12 Endo Pharmaceuticals
- 7.12.1 Endo Pharmaceuticals Corporation Information
- 7.12.2 Endo Pharmaceuticals Description and Business Overview
- 7.12.3 Endo Pharmaceuticals Opioid Receptor Agonist Sales, Revenue and Gross Margin (2017-2022)
- 7.12.4 Endo Pharmaceuticals Products Offered
- 7.12.5 Endo Pharmaceuticals Recent Development
- 7.13 Sun Pharmaceutical Industries
- 7.13.1 Sun Pharmaceutical Industries Corporation Information
- 7.13.2 Sun Pharmaceutical Industries Description and Business Overview
- 7.13.3 Sun Pharmaceutical Industries Opioid Receptor Agonist Sales, Revenue and Gross Margin (2017-2022)
- 7.13.4 Sun Pharmaceutical Industries Products Offered
- 7.13.5 Sun Pharmaceutical Industries Recent Development
- 7.14 Tris Pharma
- 7.14.1 Tris Pharma Corporation Information
- 7.14.2 Tris Pharma Description and Business Overview
- 7.14.3 Tris Pharma Opioid Receptor Agonist Sales, Revenue and Gross Margin (2017-2022)
- 7.14.4 Tris Pharma Products Offered
- 7.14.5 Tris Pharma Recent Development
- 7.15 Indivior
- 7.15.1 Indivior Corporation Information
- 7.15.2 Indivior Description and Business Overview
- 7.15.3 Indivior Opioid Receptor Agonist Sales, Revenue and Gross Margin (2017-2022)
- 7.15.4 Indivior Products Offered
- 7.15.5 Indivior Recent Development
8 Industry Chain and Sales Channels Analysis
- 8.1 Opioid Receptor Agonist Industry Chain Analysis
- 8.2 Opioid Receptor Agonist Key Raw Materials
- 8.2.1 Key Raw Materials
- 8.2.2 Opioid Receptor Agonist Distributors
- 8.3 Opioid Receptor Agonist Production Mode & Process
- 8.4 Opioid Receptor Agonist Sales and Marketing
- 8.4.1 Opioid Receptor Agonist Sales Channels
- 8.4.2 Opioid Receptor Agonist Distributors
- 8.5 Opioid Receptor Agonist Customers
9 Research Findings and Conclusion
10 Appendix
- 10.1 Research Methodology
- 10.1.1 Methodology/Research Approach
- 10.1.2 Data Source
- 10.2 Author Details
Summary:
Get latest Market Research Reports on Opioid Receptor Agonist. Industry analysis & Market Report on Opioid Receptor Agonist is a syndicated market report, published as Global and United States Opioid Receptor Agonist Market Report & Forecast 2022-2028. It is complete Research Study and Industry Analysis of Opioid Receptor Agonist market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
